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Background: Previous studies looking at the relationship between sleep duration and the 
metabolic syndrome have only used a dichotomous approach (presence/absence) and failed to 
adjust for important confounding factors. The objective of the present study was to examine the 
association between self-reported sleep duration and features of the metabolic syndrome in 
adults. Methods: A cross-sectional analysis from the Quebec Family Study (Canada) was 
conducted on 810 participants aged 18 to 65 years. Participants were categorized as short (≤6 h), 
adequate (7–8 h) or long (≥9 h) sleepers. The metabolic syndrome was defined according to the 
American Heart Association/National Heart, Lung, and Blood Institute’s criteria. Results: 
Overall, 24.6% of the sample had the metabolic syndrome. A U-shaped relationship between 
sleep duration and the prevalence of metabolic syndrome (33.3%, 22.0% and 28.8% in short, 
adequate and long sleepers, respectively) was observed (P<0.01). Only short sleepers had a 
significant increase in the odds of having the metabolic syndrome (OR = 1.76, 95% CI = 1.08–
2.84) compared to adequate sleepers after adjustment for age, sex, smoking habits, highest 
education level, total annual family income, alcohol consumption, coffee intake, menopausal 
status, daily caloric intake, and moderate-to-vigorous physical activity. Likewise, the clustered 
cardiometabolic risk score (i.e. continuous risk score based on the metabolic syndrome 
components) was significantly higher in short sleepers compared to adequate sleepers after 
adjustment for covariates (P<0.05). Conclusion: Sleeping ≤6 h per night is associated with an 
elevated cardiometabolic risk score and an increase in the odds of having the metabolic 
syndrome after adjusting for possible confounders. These results strongly suggest that short sleep 
duration is a risk factor for the metabolic syndrome. 
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Abstract
Background: Previous studies looking at the relationship between sleep duration and the metabolic syndrome have only
used a dichotomous approach (presence/absence) and failed to adjust for important confounding factors. The objective of
the present study was to examine the association between self-reported sleep duration and features of the metabolic
syndrome in adults.
Methods: A cross-sectional analysis from the Quebec Family Study (Canada) was conducted on 810 participants aged 18 to
65 years. Participants were categorized as short (#6 h), adequate (7–8 h) or long ($9 h) sleepers. The metabolic syndrome
was defined according to the American Heart Association/National Heart, Lung, and Blood Institute’s criteria.
Results: Overall, 24.6% of the sample had the metabolic syndrome. A U-shaped relationship between sleep duration and the
prevalence of metabolic syndrome (33.3%, 22.0% and 28.8% in short, adequate and long sleepers, respectively) was
observed (P,0.01). Only short sleepers had a significant increase in the odds of having the metabolic syndrome (OR = 1.76,
95% CI = 1.08–2.84) compared to adequate sleepers after adjustment for age, sex, smoking habits, highest education level,
total annual family income, alcohol consumption, coffee intake, menopausal status, daily caloric intake, and moderate-to-
vigorous physical activity. Likewise, the clustered cardiometabolic risk score (i.e. continuous risk score based on the
metabolic syndrome components) was significantly higher in short sleepers compared to adequate sleepers after
adjustment for covariates (P,0.05).
Conclusion: Sleeping #6 h per night is associated with an elevated cardiometabolic risk score and an increase in the odds
of having the metabolic syndrome after adjusting for possible confounders. These results strongly suggest that short sleep
duration is a risk factor for the metabolic syndrome.
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Introduction
Insufficient sleep has become pervasive in modern societies,
especially in children and adolescents, with 24/7 availability of
commodities [1,2]. Lack of sufficient sleep has been shown to exert
deleterious effects on a variety of systems including detectable
hormonal perturbations that may adversely impact health [3,4].
Too little or too much sleep have been associated with obesity
[5,6], type 2 diabetes [7,8], coronary heart disease [9,10],
hypertension [11,12], and premature death [13,14]. The associ-
ation between sleep duration and many health outcomes appears
to be U-shaped, suggesting that different mechanisms may operate
at either end of the sleep duration distribution [15].
The metabolic syndrome, a cluster of cardiometabolic risk
factors that predispose individuals to cardiovascular disease and
type 2 diabetes, is a critical public health problem nowadays [16].
Sleep is intricately linked to various hormonal and metabolic
systems and is likely to influence the development of the metabolic
syndrome [17]. A small number of studies have recently shown
that sleep duration is associated with the metabolic syndrome [18–
22]. However, previous studies only looked at the association
between sleep duration and the metabolic syndrome as a
dichotomous diagnosis (presence/absence), and none examined
the relationship with a clustered cardiometabolic risk score. The
clustered risk score approach is used as a means of estimating an
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individual’s global cardiometabolic risk and results in a continuous
risk score that increases statistical power [23–25].
The main objective of this observational, cross-sectional study
was to investigate the relationship between sleep duration and
features of the metabolic syndrome in adults from the greater
Quebec City area (Canada). It was hypothesized that both short
sleepers (#6 h per night) and long sleepers ($9 h per night) would
be more likely to have features of the metabolic syndrome than




All participants provided written informed consent to partici-
pate in the study. The project followed guidelines of the Medical
Research Council of Canada, and was approved by the Medical
Ethics Committee of Laval University (Quebec City, Canada).
Participants
The Quebec Family Study was initiated at Laval University in
1978. The primary objective of this study was to investigate the
role of genetics in the etiology of obesity and related cardiovascular
risk factors. In phase 1 of the study (1978 to 1981), a total of 1650
individuals from 375 families were recruited and assessed.
Recruitment was conducted irrespective of body weight during
phase 1, resulting in a cohort with a wide range of body mass
index, ranging from 13.8 to 64.9 kg/m2. In phase 2 (1989–1994)
and 3 (1995–2001), 100 families from phase 1 were retested, and
an additional 123 families with at least 1 parent and 1 offspring
with a body mass index of 32 kg/m2 or higher were added to the
cohort. Families were recruited through the media and were all
French Canadians from the greater Quebec City area. Details of
recruitment procedures have been published elsewhere [26]. This
cohort thus represents a mixture of random sampling and
ascertainment through obese individuals. The present analyses
are based on participants tested in phases 2 and 3 because some
measurements were not available in phase 1. Adults between 18
and 65 years of age were selected for cross-sectional analyses
(n = 810).
Table 1. Baseline characteristics of participants according to sleep duration group.
#6 h per
night (n = 90)
7–8 h per night
(n = 571) $9 h per night (n = 149) P
Age (years) 40.8613.3 40.0614.0 39.8615.2 0.86
Sex
Men (%) 48 44 36
Women (%) 52 56 64 0.26
Body mass index (kg/m2) 29.567.3* 26.867.0 28.669.3 ,0.01
Waist circumference (cm) 93.1618.6* 87.1617.5 90.3621.1 ,0.01
Fasting glucose (mmol/L) 5.4460.88 5.3161.04 5.6061.96 0.14
Fasting insulin (pmol/L) 86.1660.5* 71.6659.4 87.1669.0* 0.01
Systolic blood pressure (mm Hg) 116615 117616 120617 0.20
Diastolic blood pressure (mm Hg) 74613 72610 74610 0.16
Fasting triglycerides (mmol/L) 1.6160.92 1.5261.55 1.5360.85 0.95
HDL cholesterol (mmol/L) 1.1860.34 1.2360.32 1.2560.33 0.48
Smoking habits
Nonsmoker (%) 68 78 84
Smoker (%) 32*{ 22 16 0.03
Highest education level
High school (%) 55 41 47
Pre-university level (%) 29 35 33
University (%) 16 24 20 0.06
Total annual family income ($C) 49,937633,373* 56,284628,806 47,738626,447* 0.01
Alcohol consumption (g/day) 12.8614.2 8.1616.1 7.3617.3 0.15
Coffee intake (cups/day) 3.0062.28{ 2.8462.53 2.0461.68 ,0.01
Menopausal status
In menopause (%) 15 20 24
Not in menopause (%) 85 80 76 0.28
Energy intake (kcal/day) 2,3506692 2,3626716 2,2916691 0.76
MVPA (min/day) 39666*{ 24637 19631 ,0.01
Abbreviations: HDL, high-density lipoprotein; MVPA, moderate-to-vigorous physical activity. Values are mean 6 SD or n (%).
Statistical significance was assessed by analysis of variance with continuous variables and by a chi-squared test with categorical variables. A Tukey post-hoc test was
used to contrast mean differences. *Significantly different from the 7–8 h sleep group. {Significantly different from the $9 h sleep group.
doi:10.1371/journal.pone.0072832.t001
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The Quebec Family Study database is not publicly available.
However, it has been used repeatedly over the last 30 years in a
large number of collaborative studies. Investigators who are
interested in using some of the data need to contact one of the
senior investigators (Claude Bouchard, Angelo Tremblay or Jean-
Pierre Després).
Sleep Duration Assessment
The number of hours of sleep was assessed with a question that
was inserted into a self-administered questionnaire on physical
activity participation. The question was formulated as follows:
‘‘On average, how many hours do you sleep a day?’’ The
participants were classified into 3 sleep duration groups: short
sleepers (#6 h of sleep), adequate sleepers (7–8 h of sleep) and
long sleepers ($9 h of sleep), in agreement with recent papers
[27,28]. The participants were classified into 3 sleep duration
groups because of the U-shaped relationship that has been
previously noted between sleep duration and most health
outcomes. Epidemiological evidence indicates that a daily sleep
duration of 7–8 h is optimal, and is associated with an overall good
health status in adults [29].
Features of the Metabolic Syndrome and
Cardiometabolic Risk Score
Components of the metabolic syndrome were assessed in the
morning following a 12-h overnight fast. Systolic (SBP) and
diastolic (DBP) blood pressure measurements were obtained by
trained staff, using a mercury sphygmomanometer and cuff size
appropriate to the participant’s arm circumference. Blood pressure
was calculated as the mean of two consecutive readings obtained
on the right arm, in a seated position, and following 10 minutes of
rest. Body weight, height and waist circumference (WC) (midpoint
of the lowest rib and iliac crest) were measured according to
standardized procedures [30], and body mass index (BMI) was
calculated as body weight divided by height squared (kg/m2).
Study staff also collected a venous blood sample to measure fasting
serum lipids, glucose, and insulin concentrations, as previously
described [27]. The metabolic syndrome was defined according to
the American Heart Association/National Heart, Lung, and
Blood Institute’s criteria [31] as the presence of three or more of
the following risk factors: (i) waist circumference greater than
102 cm in men or greater than 88 cm in women; (ii) fasting serum
glucose of 5.6 mmol/L or greater, or the use of oral hypoglycemic
medication; (iii) systolic and diastolic blood pressures of at least
130 mm Hg and 85 mm Hg, respectively, or the use of
antihypertensive medication; (iv) serum triglyceride levels of
1.7 mmol/L or higher, or the use of medication for hypertriglyc-
eridemia; and (v) high-density lipoprotein (HDL) cholesterol levels
of less than 1.03 mmol/L in men or 1.29 mmol/L in women, or
the use of medication for low HDL cholesterol. Furthermore, a
clustered cardiometabolic risk score was calculated for each
participant by adding up Z scores for each variable as follows:
Clustered Cardiometabolic Risk Score = 2zHDL+zInsulin+z-
Glucose+zTriglycerides+(zBMI+zWC)/2+ (zSBP+zDBP)/2.
This clustered risk score was used as a means of estimating an
individual’s global cardiometabolic risk. In contrast to a dichot-
omous metabolic syndrome diagnosis, this approach provides a
continuous risk score that increases statistical power, and has been
used successfully in several recent investigations [23–25].
Covariates
Numerous covariates were measured via self-reported question-
naires and reviewed during an interview with the research staff.
These questionnaires (including sleep) were filled out the same day
as the metabolic syndrome measures were obtained. Covariates
included age, sex, smoking habits (smoker or nonsmoker), highest
education level (high school, pre-university level [CEGEP for
Quebec], university), total annual family income (Canadian dollars
per year), coffee intake (number of cups per day), and menopausal
status (in menopause or not in menopause). Additionally, daily
energy intake (kcal/day) and alcohol consumption (g/day) were
assessed with a 3-day food record [32]. This method of dietary
assessment has been shown to provide a relatively reliable
measurement of food intake in this population [32]. Finally, daily
Table 2. Proportion of participants in each sleep duration category who meet criteria for the metabolic syndrome.1
#6 h per night (n = 90) 7–8 h per night (n = 571) $9 h per night (n = 149) P
Criteria 38.9* 27.3 34.9 0.03
Abdominal adiposity 29.2 23.4 24.8 0.54
Glucose 22.2 20.8 28.8 0.12
Blood pressure 34.4 29.3 31.1 0.61
Triglycerides 58.8*{ 44.7 43.9 ,0.01
HDL cholesterol
Number of metabolic abnormalities
None 23.3 33.2 29.5 0.13
One component 25.5 26.6 27.5 0.94
Two components 17.8 18.0 14.1 0.51
Three or more (metabolic syndrome) 33.3* 22.0 28.8 ,0.01
1Metabolic syndrome defined according to the American Heart Association/National Heart, Lung, and Blood Institute’s criteria (AHA/NHLBI) as the presence of three or
more of the following: (1) waist circumference greater than 102 cm in men or greater than 88 cm in women; (2) fasting serum glucose of 5.6 mmol/L or greater, or use
of oral hypoglycemic medication; (3) blood pressure of 130 mm Hg systolic, 85 mm Hg diastolic or higher, or use of antihypertensive medication; (4) serum triglycerides
of 1.7 mmol/L or higher, or medication for hypertriglyceridemia; and (5) high-density lipoprotein (HDL) cholesterol of less than 1.03 mmol/L in men or 1.29 mmol/L in
women, or use of medication for low HDL cholesterol.
Abbreviations: HDL, high-density lipoprotein. Data are presented as percentage. Statistical significance was assessed by a chi-squared test.
A post-hoc test was used to contrast differences between sleep duration groups. *Significantly different from the 7–8 h sleep group.
{Significantly different from the $9 h sleep group.
doi:10.1371/journal.pone.0072832.t002
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physical activity level was evaluated with a 3-day physical activity
diary, as previously described [33]. Moderate-to-vigorous physical
activity participation over 3 days was used for statistical analyses
(min/day). These covariates were chosen because of their
association with sleep duration and/or the metabolic syndrome.
Statistical Analysis
Since there was no statistically significant gender interaction
between sleep duration and the outcome variable (i.e. metabolic
syndrome), data for both sexes were combined to improve clarity
and maximize power. Descriptive characteristics of participants by
sleep duration group were compared by analysis of variance
(continuous variables) and chi-squared test (categorical variables).
A Tukey post-hoc test was used to contrast mean differences.
Logistic regression analysis was used to predict the odds of having
the metabolic syndrome in short and long sleepers. The 7–8 h
category was used as the reference group. The model was adjusted
for age, sex, smoking habits, highest education level, total annual
family income, alcohol consumption, coffee intake, menopausal
status, daily caloric intake, and moderate-to-vigorous physical
activity participation. Odds ratios (OR) and 95% confidence
intervals (CI) were reported. Finally, clustered cardiometabolic risk
scores were compared between sleep duration groups using an
analysis of covariance, followed by a Tukey post-hoc test to
contrast mean differences. The model was adjusted for the above-
mentioned covariates. A 2-tailed P value of less than 0.05 was the
threshold to indicate statistical significance. All statistical analyses
were performed using JMP version 10 (SAS Institute, Cary, NC).
Table 3. Multivariate associations between sleep duration and the metabolic syndrome.1
#6 h per night (n = 90)
7–8 h per night
(n = 571)
$9 hours per night
(n = 149)
OR 95% CI Reference OR 95% CI
Model 1 2.02 1.32–3.23 1.00 1.46 0.95–2.14
Model 2 1.80 1.15–2.98 1.00 1.43 0.91–2.09
Model 3 1.76 1.08–2.84 1.00 1.35 0.83–1.99
1Metabolic syndrome defined according to the American Heart Association/National Heart, Lung, and Blood Institute’s criteria [31].
Model 1: unadjusted odds ratio.
Model 2: adjusted for age, sex, smoking habits, highest education level, total annual family income, alcohol consumption, coffee intake, and menopausal status.
Model 3: adjusted for daily caloric intake and moderate-to-vigorous physical activity in addition to age, sex, smoking habits, highest education level, total annual family
income, alcohol consumption, coffee intake, and menopausal status.
Abbreviations: OR, odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0072832.t003
Figure 1. Clustered cardiometabolic risk score between sleep duration groups. Legend: Data are presented as mean values with standard
errors of the mean. Clustered cardiometabolic risk scores between sleep duration categories were compared by analysis of covariance, followed by a
Tukey post-hoc test to contrast mean differences. The model was adjusted for age, sex, smoking habits, highest education level, total annual family
income, alcohol consumption, coffee intake, menopausal status, daily caloric intake, and moderate-to-vigorous physical activity as covariates. P,0.05
for the ANOVA analysis. *P,0.05 vs. adequate sleepers. Short sleepers (#6 h of sleep per night; n = 90), adequate sleepers (7–8 h of sleep per night;
n = 571), and long sleepers ($9 h of sleep per night; n = 149).
doi:10.1371/journal.pone.0072832.g001
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Results
Baseline characteristics of participants within each sleep
duration group are shown in Table 1. Among the 810 participants
of this study, all of them were Caucasians, 38 (4.7%) had
diagnosed type 2 diabetes, and 95 (11.7%) had diagnosed
hypertension. Short sleepers had a significantly higher BMI and
waist circumference compared to those sleeping 7 to 8 h per night.
Fasting insulin concentrations were significantly different across
sleep duration groups in a U-shaped curve. A significantly higher
proportion (32%) of short sleepers were smokers, compared to
adequate (22%) and long (16%) sleepers. Individuals in the 7–8 h
sleep category had a significantly higher total annual income and
short sleepers reported drinking more coffee than the long sleepers.
Finally, short sleepers engaged in more moderate-to-vigorous
physical activity compared to the two other sleep categories.
A comparison of the prevalence of the components and the
number of metabolic abnormalities among participants with
different sleep durations is shown in Table 2. Individuals sleeping
7 to 8 h per night had the lowest prevalence of abdominal
adiposity and those sleeping less than 6 h per night the greatest
prevalence of low HDL cholesterol concentrations. Overall, 199
participants (24.6% of the sample) had the metabolic syndrome. A
U-shaped relationship between sleep duration and the prevalence
of metabolic syndrome (33.3%, 22.0% and 28.8% in short,
adequate and long sleepers, respectively) was observed (P,0.01).
The results of the logistic regression analysis assessing the
relationship between sleep duration and the metabolic syndrome
are summarized in Table 3. Short sleepers had significantly greater
odds of having the metabolic syndrome (OR = 1.76, 95%
CI = 1.08–2.84) compared to those sleeping 7 to 8 h per night,
after adjusting for covariates. However, long sleep duration was
not associated with an increase in the odds of having the metabolic
syndrome (either unadjusted or adjusted models).
Finally, clustered cardiometabolic risk scores were compared
between sleep duration groups (Figure 1). After adjusting for age,
sex, smoking habits, highest educational level, total annual family
income, alcohol consumption, coffee intake, menopausal status,
daily caloric intake and moderate-to-vigorous physical activity
participation, the clustered cardiometabolic risk score was
significantly higher in short sleepers compared to adequate
sleepers (P,0.05).
Discussion
Collectively, a U-shaped relationship (or inversed J-shaped
association) was observed between sleep duration and the
prevalence of metabolic syndrome. Sleeping less than 6 h or more
than 9 h per night was associated with a greater prevalence of
meeting criteria for the metabolic syndrome compared to sleeping
7–8 h a day in adults. After adjustment for possible confounders,
only short sleep duration was associated with clustered cardiome-
tabolic risk and an increase in the odds of meeting criteria of the
metabolic syndrome. Taken together, these results suggest that
long sleep duration does not convincingly increase the risk of being
diagnosed with the metabolic syndrome while short sleep duration
seems to play an important role. The present results emphasize
that short sleeping habits should be regarded as another important
risk factor of the metabolic syndrome.
The results of the present study are somewhat concordant with
the few studies published to date on the association between sleep
duration and the metabolic syndrome. Wu et al. [18] reported that
short sleep duration was associated with a higher prevalence of the
metabolic syndrome in an apparently healthy population from
Taiwan. Likewise, short sleep duration was associated with the
presence of metabolic syndrome in other studies [21,22]. Both
short and long sleep durations were also related to an increased
risk of the metabolic syndrome and its components in other studies
[34,35]. Similarly, Hall et al. [19] showed that sleep was
associated with the metabolic syndrome in a multi-ethnic cohort
of midlife women involved in the SWAN Sleep Study. In contrast,
Arora et al. [20] reported that long sleep duration was associated
with a greater risk of metabolic syndrome in older Chinese. As
discussed by the authors, the finding that short sleep duration was
unrelated to the metabolic syndrome and its components after
adjustment for covariates was not in line with the available
evidence and could possibly be explained by an attenuation of the
relationship with age, the presence of obstructive sleep apnea (not
available in their study) or long sleep being a consequence of ill
health.
The mechanisms that underlie the association between short
sleep duration and the metabolic syndrome are not well
understood but could involve adverse physiologic and hormonal
changes, including decreased glucose tolerance, increased insulin
resistance, increased sympathetic tone, increased blood pressure,
and elevated blood cortisol concentrations as shown in experi-
ments with short-term sleep restriction [3,4,9,17]. Low-grade
inflammation is also increased with short sleep, with possible
implications not only for cardiovascular risk but also for other
chronic conditions including cancer [36]. Lack of sleep has also
been shown to increase food intake and contribute to weight gain
and obesity [37]. Although self-reported food intake was not
significantly different between sleep duration groups in the present
study, the abdominal adiposity criterion was met by 39% of short
sleepers. Thus, the relationship between shortened sleep duration
and cardiometabolic risk could be mediated, in part, by individual
associations with obesity, glucose metabolism, and their down-
stream pathophysiologic consequences. However, future experi-
mental studies will be needed to elucidate the pathways between
insufficient sleep and cardiometabolic risk, and to rule out any
reverse causation.
Extensive epidemiological evidence suggests that a sleep
duration of 7–8 h per night in adults is associated with the
maintenance of good health [29]. A growing body of evidence
shows that insufficient sleep is associated with mental distress,
depression, anxiety, impaired academic performance, weight gain,
hypertension, diabetes, high cholesterol levels, premature death,
and adverse health behaviors such as physical inactivity and poor
eating habits [37]. There is thus a need to more clearly understand
the determinants and mechanisms involved in regulating sleep
duration and sleep patterns, and to identify high-risk individuals
who are in greater need of preventive strategies. Results of this
study showed that cigarette smoking, low socio-economic status,
coffee intake, and moderate-to-vigorous physical activity partici-
pation were all associated with short sleep duration. However,
short sleep duration was still associated with an increase in the
odds of having the metabolic syndrome after adjusting for these
covariates, thus suggesting that the relationship was independent
of these covariates and potential confounders.
The present results need to be interpreted in light of the
following. First, the direction of causality cannot be determined
from cross-sectional data. Second, although good agreement has
been found in previous studies between self-reported sleep
durations and those obtained through actigraphic monitoring
[38,39], the single question approach does not provide informa-
tion on sleep quality and our sleep instrument has not been
validated. Third, the external generalizability of our findings may
be restricted to adults of Western European descent. Finally, there
are the commonly acknowledged limitations associated with self-
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reported food intake and physical activity participation (e.g. recall
bias), and the possibility of residual confounding by unmeasured
variables is always a possibility in observational studies (e.g.
depression, obstructive sleep apnea, insomnia, medications). In
particular, the 7–8 h sleep group had higher annual family income
and education level; however, adjusting for these two variables
does not adequately capture aspects of socio-economic status such
as the degree of order or regularity in a home, which is conducive
to good sleep hygiene, or neighborhood characteristics.
In summary, the present study provides evidence that short
sleep duration is associated with an increased clustered cardiome-
tabolic risk and greater odds of having the metabolic syndrome in
adults. Future studies should examine other dimensions of sleep
(e.g. sleep quality, timing, architecture, consistency and continuity)
which may be related to the metabolic syndrome and its
components.
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